172 related articles for article (PubMed ID: 36427784)
1. Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors.
Hong S; Zhao J; Wang S; Wang H; Lee JH; Farhadfar N; McGuirk JP; Savani BN; Shahrukh HK; Stiff P; Khera N; Hahn T; Loren AW; Jaglowski SM; Wood WA; Saber W; Cerny J; Holtan SG; Reynolds JM; Deol A; Jim H; Uberti J; Whalen V; Yi JC; Preussler J; Baker KS; Shaw BE; Devine S; Syrjala K; Majhail NS; Wingard JR; Al-Mansour Z
Transplant Cell Ther; 2023 Mar; 29(3):202.e1-202.e8. PubMed ID: 36427784
[TBL] [Abstract][Full Text] [Related]
2. Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell Transplantation.
Rotz SJ; Yi JC; Hamilton BK; Wei W; Preussler JM; Cerny J; Deol A; Jim H; Khera N; Hahn T; Hashmi SK; Holtan S; Jaglowski SM; Loren AW; McGuirk J; Reynolds J; Saber W; Savani BN; Stiff P; Uberti J; Wingard JR; Wood WA; Baker KS; Majhail NS; Syrjala KL
Transplant Cell Ther; 2022 Oct; 28(10):701.e1-701.e7. PubMed ID: 35872304
[TBL] [Abstract][Full Text] [Related]
3. Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors.
Farhadfar N; Weaver MT; Al-Mansour Z; Yi JC; Jim HSL; Loren AW; Majhail NS; Whalen V; Uberti J; Wingard JR; Lynch Kelly D; Syrjala KL
Transplant Cell Ther; 2022 Sep; 28(9):606.e1-606.e8. PubMed ID: 35662590
[TBL] [Abstract][Full Text] [Related]
4. Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis.
Syrjala KL; Sutton SK; Jim HS; Knight JM; Wood WA; Lee SJ; Jacobsen PB; Abidi MH; Yi JC
Cancer; 2017 Apr; 123(8):1416-1423. PubMed ID: 27893933
[TBL] [Abstract][Full Text] [Related]
5. Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
Chakraborty R; Yi J; Rybicki L; Preussler J; Deol A; Loren A; Savani B; Jim HSL; Cerny J; Reynolds J; Whitten J; Wingard JR; McGuirk JP; Uberti J; Khera N; Stiff P; Jaglowski SM; Hashmi S; Holtan SG; Devine S; Hahn T; Whalen VL; Saber W; Wood W; Baker KS; Syrjala K; Majhail NS
Transplant Cell Ther; 2023 Jun; 29(6):388.e1-388.e6. PubMed ID: 36870388
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact of Pretransplantation Quality of Life and Its Post-Transplantation Longitudinal Change after Allogeneic Hematopoietic Cell Transplantation: A Prospective Study That Administered the Short-Form Health Survey (SF-12) and EuroQol 5.
Kurosawa S; Yamaguchi T; Mori A; Tsukagoshi M; Okuda I; Ikeda M; Fuji S; Yamashita T; Ogawa C; Ito A; Tanaka T; Inamoto Y; Kim SW; Fukuda T
Transplant Cell Ther; 2021 Nov; 27(11):935.e1-935.e9. PubMed ID: 34371214
[TBL] [Abstract][Full Text] [Related]
7. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
Shaw BE; Syrjala KL; Onstad LE; Chow EJ; Flowers ME; Jim H; Baker KS; Buckley S; Fairclough DL; Horowitz MM; Lee SJ
Cancer; 2018 Feb; 124(4):841-849. PubMed ID: 29072787
[TBL] [Abstract][Full Text] [Related]
8. Social support as a moderator of healthcare adherence and distress in long-term hematopoietic cell transplantation survivors.
Nørskov KH; Yi JC; Crouch ML; Fiscalini AS; Flowers MED; Syrjala KL
J Cancer Surviv; 2021 Dec; 15(6):866-875. PubMed ID: 33420905
[TBL] [Abstract][Full Text] [Related]
9. Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies.
Ullrich CK; Baker KK; Carpenter PA; Flowers ME; Gooley T; Stevens S; Krakow EF; Oshima MU; Salit RB; Vo P; Connelly-Smith L; Lee SJ; Wood WA
Transplant Cell Ther; 2023 Mar; 29(3):200.e1-200.e8. PubMed ID: 36494015
[TBL] [Abstract][Full Text] [Related]
10. Resilience, health, and quality of life among long-term survivors of hematopoietic cell transplantation.
Rosenberg AR; Syrjala KL; Martin PJ; Flowers ME; Carpenter PA; Salit RB; Baker KS; Lee SJ
Cancer; 2015 Dec; 121(23):4250-7. PubMed ID: 26288023
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors.
Majhail NS; Murphy E; Laud P; Preussler JM; Denzen EM; Abetti B; Adams A; Besser R; Burns LJ; Cerny J; Drexler R; Hahn T; Idossa L; Jahagirdar B; Kamani N; Loren A; Mattila D; McGuirk J; Moore H; Reynolds J; Saber W; Salazar L; Schatz B; Stiff P; Wingard JR; Syrjala KL; Baker KS
Haematologica; 2019 May; 104(5):1084-1092. PubMed ID: 30514795
[TBL] [Abstract][Full Text] [Related]
12. Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors.
Syrjala KL; Crouch ML; Leisenring WM; Flowers MED; Artherholt SB; Fiscalini AS; Romano E; Romano JM; Martin PJ; Yi JC
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1692-1698. PubMed ID: 29753161
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
Wood WA; Le-Rademacher J; Syrjala KL; Jim H; Jacobsen PB; Knight JM; Abidi MH; Wingard JR; Majhail NS; Geller NL; Rizzo JD; Fei M; Wu J; Horowitz MM; Lee SJ
Cancer; 2016 Jan; 122(1):91-8. PubMed ID: 26439325
[TBL] [Abstract][Full Text] [Related]
14. Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study.
Sun CL; Kersey JH; Francisco L; Armenian SH; Baker KS; Weisdorf DJ; Forman SJ; Bhatia S
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1073-80. PubMed ID: 23583827
[TBL] [Abstract][Full Text] [Related]
15. Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant.
Wu NL; Phipps AI; Krull KR; Syrjala KL; Carpenter PA; Connelly-Smith LS; Flowers ME; Krakow EF; Ueda Oshima M; Lee SJ; Chow EJ
Blood Adv; 2022 Jul; 6(14):4347-4356. PubMed ID: 35584396
[TBL] [Abstract][Full Text] [Related]
16. Psychometric properties of the Cancer and Treatment Distress (CTXD) measure in hematopoietic cell transplantation patients.
Syrjala KL; Yi JC; Langer SL
Psychooncology; 2016 May; 25(5):529-35. PubMed ID: 26130497
[TBL] [Abstract][Full Text] [Related]
17. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
Fulcher J; Blanchard AP; Bredeson C; van Walraven C
Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
[TBL] [Abstract][Full Text] [Related]
18. Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial.
Knight JM; Syrjala KL; Majhail NS; Martens M; Le-Rademacher J; Logan BR; Lee SJ; Jacobsen PB; Wood WA; Jim HSL; Wingard JR; Horowitz MM; Abidi MH; Fei M; Rawls L; Rizzo JD
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2256-2263. PubMed ID: 27565521
[TBL] [Abstract][Full Text] [Related]
19. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.
Khera N; Storer B; Flowers ME; Carpenter PA; Inamoto Y; Sandmaier BM; Martin PJ; Lee SJ
J Clin Oncol; 2012 Jan; 30(1):71-7. PubMed ID: 22147737
[TBL] [Abstract][Full Text] [Related]
20. Driving Distance and Patient-Reported Outcomes in Hematopoietic Cell Transplantation Survivors.
Banerjee R; Yi JC; Majhail NS; Jim HSL; Uberti J; Whalen V; Loren AW; Syrjala KL
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2132-2138. PubMed ID: 32781287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
